Publicaciones en las que colabora con ANA MARIA PILAR GONZALEZ RODRIGUEZ (16)

2023

  1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

2021

  1. Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 8

  2. Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 9

2020

  1. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

    Bone Marrow Transplantation

2019

  1. NK cell-based immunotherapy in cancer metastasis

    Cancers, Vol. 11, Núm. 1

  2. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

    Frontiers in Immunology, Vol. 10

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

2017

  1. Aprendizaje basado en casos clínicos en Hematología a través de un wiki colaborativo en UniOvi virtual (PAINN16-007)

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

  2. Aprendizaje basado en casos clínicos en Hematología a través de una wiki colaborativa en el Campus virtual de la Universidad de Oviedo

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

  3. Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

    OncoImmunology, Vol. 6, Núm. 10

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

    BioMed Research International, Vol. 2014

  3. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology

2012

  1. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: Association with soluble MICA shedding

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 8, pp. 1201-1210

2011

  1. Conceptual aspects of self and nonself discrimination

    Self/Nonself - Immune Recognition and Signaling, Vol. 2, Núm. 1, pp. 19-25

2010

  1. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 51, Núm. 10, pp. 1829-1836